Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD30+ malignancies

Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD30+ malignancies

US Patent 12391764 · Granted Aug 19, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD30 antibodies2025
Anti-CD30 antibodies2025
Methods and compositions for vaccinating and boosting cancer patients2025
Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage2025
T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy2024
T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy2024
Recombinant PD-L1 peptides and methods of use2024
Recombinant PD-L1 peptides and methods of use2024
Methods and compositions for cells expressing a chimeric intracellular signaling2024
Methods and compositions for cells expressing a chimeric intracellular signaling2024
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies2023
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies2023